Ultragenyx Pharmaceutical In

RARENASDAQ · US

Holders

REDUCEDT+30
Huizenga Theodore Alan
Ultragenyx Pharmaceutical In · NASDAQ
−1,283 sh · $17.4K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDStale
Huizenga Theodore Alan
Ultragenyx Pharmaceutical In · NASDAQ
−161 sh · $2.3K
Filed 8 Sept 2026SEC Form 4view source
DISCLOSEDStale
Renaissance Technologies
Ultragenyx Pharmaceutical In · NASDAQ
561,700 sh · $11.8M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Ultragenyx Pharmaceutical In · NASDAQ
2,205,820 sh · $46.2M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Ultragenyx Pharmaceutical In · NASDAQ
5,603,352 sh · $230.3M
Filed 30 Jun 2024SEC 13Fview source